Aimovig 140 mg (Erenumab SOLUTION) 140 MG

Aimovig 140 mg is a subcutaneous solution containing erenumab for migraine prevention. This medication is designed to help reduce the frequency and severity of migraines in adults. Learn more about its uses and effects.

Strength

140 MG

Manufacturer / TM Owner

NOVARTIS PHARMACEUTICALS CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Aimovig 140 mg is primarily used for migraine prevention. It is a calcitonin gene-related peptide (CGRP) antagonist, which works by targeting specific pathways involved in migraine attacks. People often ask, 'What is Aimovig used for?' and the answer is that it is intended for those who experience frequent migraines and are looking for a preventive treatment option.

Side Effects

Common effects of Aimovig 140 mg may include injection site reactions, such as redness, pain, or swelling. Some users might also experience constipation, muscle tension, or fatigue. These effects vary among individuals and are not experienced by everyone who uses the medication.

Precautions & Warnings

Aimovig 140 mg should be used with caution in individuals with a history of allergic reactions to erenumab or any of its components. It is important to follow the prescribed administration guidelines and consult a healthcare provider before starting this treatment. Always store the solution properly to maintain its efficacy.

Avoid Interactions

Aimovig 140 mg may interact with other medications, including those that affect the immune system or blood pressure. It is advisable to inform your healthcare provider about all the medications you are currently taking to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare professional.

Frequently Asked Questions

Aimovig is used for the prevention of migraines in adults. It is designed to reduce the frequency and severity of migraine attacks.

Aimovig is administered as a subcutaneous injection, typically once a month. The solution comes in a pre-filled pen for easy self-administration.

Common side effects may include injection site reactions, constipation, muscle tension, and fatigue. These effects vary among individuals.

Aimovig is not suitable for everyone. It should be used with caution in individuals with a history of allergic reactions to erenumab or its components.

Aimovig should be stored in the refrigerator between 2°C to 8°C. It should not be frozen and should be protected from light.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.